Abstract
This AOP describes the linkages between agonism of the estrogen receptor (ER) and population relevant impacts on reproductive function in a range of oviparous vertebrates including amphibia, birds and fish. The information in this AOP for ER agonism does not apply to mammalian species and also not to invertebrates.
Amphibians are sensitive to ER agonists during the transformation from larval tadpole to juvenile frog as these include critical periods of metamorphic development and sex differentiation that may be particularly sensitive to endocrine disruption. Larvae exposed to ER agonists during mid-metamorphosis show developmental effects, a subsequent strong female-biased sex ratio which suggests that transient early life-stage exposure to ER agonists can produce effects on the reproductive organs that persist into the beginning of adult life-stages. Birds are also known to be vulnerable to ER agonists causing disruption of estrogen-regulated functions such as sexual differentiation and sexual behaviour. Model species such as the Japanese quail have been widely used as a model for studying various long-term effects after embryonic exposure to ER agonists. In terms of teleost fish, exposure to ER agonists leads to a suite of adverse outcomes depending upon whether exposures occur during or beyond the larval, juvenile and adult life-stages. For example, aquatic exposure to potent ER agonists during the larval and juvenile life-stages may leads to gonadal and renal pathology and skewed-sex ratios in adult fish (potentially 100% females). Larval, juvenile and adult male fish exposed to the same ER agonists display abnormal plasma or whole body levels of vitellogenin (VTG). Cumulative fecundity in adult populations is also adversely affected by ER agonists and this is an important endpoint in the OECD Test Guideline 229 Fish Short Term Reproduction Assay. In summary, this AOP has utility in supporting the application of test methods for detecting ER agonists, or in silico predictions of the ability of chemicals to act as ER agonists and cause impaired sexual development and reproductive dysfunction.
Overall Assessment of the AOP
In terms of the criteria associated with Key Events in this AOP, the following observations have been made as shown in parentheses []:
1. concordance of dose-response relationships?; [There is strong dose-response relationship concordance over a wide range of experimental studies using ER agonists in well-defined animals models, including amphibians, birds and fish];
2. temporal concordance among the key events and adverse effect?; [There is strong temporal concordance from partial and full life-cycle studies using ER agonists in well-defined animals models];
3. strength, consistency, and specificity of association of adverse effect and initiating event?; [In fish, there is a strong and consistent association between ER agonist exposure, disruption of sexual development and reproductive dysfunction. The same is true for amphibians and birds although the published studies are less numerous.];
4. biological plausibility, coherence, and consistency of the experimental evidence?; [For the oviparous species frequently studied to date, there is a high level of biological plausibility, coherence, and consistency across the published experimental evidence];
5. alternative mechanisms that logically present themselves and the extent to which they may distract from the postulated AOP?; [Other mechanisms of relevance to estrogen-mediated sexual development include the disruption of the steroidogenic pathways (eg see the AOP for aromatase inhibition in fish) and this alterative AOP should be considered alongside ER agonism in the context of elevated plasma VTG levels, disrupted sexual development of reproductive dysfunction. The possibility of other AOPs arisign should be kept in mind through critical analysis of the updated pree-reviewed literature];
6. uncertainties, inconsistencies and data gaps?; [An important aspect of uncertainty is quantifying the degree to which disrupted sexual development leads to a population-relevant impact via reproductive dysfunction. Experimental and validated population modelling is a key need to address this data gap and uncertainty. In the author's view, there are no major scientific inconsistencies with regard to the ER agonism AOP and associated Key Events].
Domain of Applicability
Life Stage Applicability
| Life Stage |
Evidence |
| Juvenile |
High |
| Embryo |
High |
Taxonomic Applicability
| Term |
Scientific Term |
Evidence |
Links |
| fathead minnow |
Pimephales promelas |
High |
NCBI
|
| Japanese quail |
Coturnix japonica |
High |
NCBI
|
| northern leopard frog |
Rana pipiens |
High |
NCBI
|
| medaka |
Oryzias latipes |
High |
NCBI
|
| zebrafish |
Danio rerio |
High |
NCBI
|
Sex Applicability
Life Stage Applicability,
Taxonomic Applicability,
Sex Applicability
In terms of the taxonomic domains of applicability, exposure to ER agonists is capable of disrupting sexual development and causing reproductive dysfunction in oviparous species suchas amphibians, birds and fish (see examples of peer-revised literature cited below).
References
Dang, Z., Traas, T., Vermeire, T. (2011) Evaluation of the fish short term reproduction assay for detecting endocrine disrupters. Chemosphere 85: 1592-1603
Halldin, K., Axelsson, J., Brunström, B., (2005) Effects of endocrine modulators on sexual differentiation and reproductive function in male Japanese quail. Brain Research Bulletin 65: 211-218
Hogan, N.S., Duarte, P., Wade, M.G., Lean, D.R.S., Trudeau, V.L. (2008) Estrogenic exposure affects metamorphosis and alters sex ratios in the northern leopard frog (Rana pipiens): Identifying critically vulnerable periods of development. General and Comparative Endocrinology 156: 515-523
Hutchinson T.H. (2002) Impacts of endocrine disrupters on fish development: opportunities for adapting OECD Test Guideline 210. Environmental Sciences 9: 439-450
Länge R., Hutchinson T.H., Croudace C.P., Siegmund F., Schweinfurth H., Hampe P., Panter G.H., Sumpter J.P. (2001) Effects of the synthetic oestrogen 17-ethinylestradiol over the life-cycle of the fathead minnow. Environmental Toxicology and Chemistry 20: 1216–1227
Leino, R.L., Jensen,K.M., Ankley, G.T. (2005) Gonadal histology and characteristic histopathology associated with endocrine disruption in the adult fathead minnow (Pimephales promelas). Environmental Toxicology and Pharmacology 19: 85-98
Ottinger, M.N., Carro, T., Bohannon, M., Baltos,L., Marcell, A.M., McKernan, M., Dean, K.M., Lavoie, E., Abdelnabi, M. (2013) Assessing effects of environmental chemicals on neuroendocrine systems: Potential mechanisms and functional outcomes. General and Comparative Endocrinology 190: 194-202
Appendix 1
List of MIEs in this AOP
Short Name: Agonism, Estrogen receptor
Key Event Component
| Process |
Object |
Action |
| estrogen receptor activity |
estrogen receptor |
increased |
AOPs Including This Key Event
Biological Context
| Level of Biological Organization |
| Molecular |
List of Key Events in the AOP
Short Name: Reduction, Cumulative fecundity and spawning
Key Event Component
| Process |
Object |
Action |
| egg quantity |
|
decreased |
AOPs Including This Key Event
Stressors
| Name |
| Tris(1,3-dichloropropyl)phosphate - TDCPP |
Biological Context
| Level of Biological Organization |
| Individual |
Evidence for Perturbation by Stressor
Tris(1,3-dichloropropyl)phosphate - TDCPP
Reduction of cumulative fecundity and spawning following exposure to low levels of TDCIPP (15, 46 and 90 nM) has been reported in 3 different zebrafish studies (Liu et al., 2013; Wang et al., 2015a; Zhu et al., 2015).
Domain of Applicability
Taxonomic Applicability
| Term |
Scientific Term |
Evidence |
Links |
| fathead minnow |
Pimephales promelas |
High |
NCBI
|
| Fundulus heteroclitus |
Fundulus heteroclitus |
High |
NCBI
|
| Oryzias latipes |
Oryzias latipes |
High |
NCBI
|
Life Stage Applicability
| Life Stage |
Evidence |
| Adult, reproductively mature |
High |
Cumulative fecundity and spawning can, in theory, be evaluated for any egg laying animal.
Key Event Description
Spawning refers to the release of eggs. Cumulative fecundity refers to the total number of eggs deposited by a female, or group of females over a specified period of time.
How it is Measured or Detected
In laboratory-based reproduction assays (e.g., OECD Test No. 229; OECD Test No. 240), spawning and cumulative fecundity can be directly measured through daily observation of egg deposition and egg counts.
In some cases, fecundity may be estimated based on gonado-somatic index (OECD 2008).
Regulatory Significance of the AO
Cumulative fecundity is the most apical endpoint considered in the OECD 229 Fish Short Term Reproduction Assay. The OECD 229 assay serves as screening assay for endocrine disruption and associated reproductive impairment (OECD 2012). Fecundity is also an important apical endpoint in the Medaka Extended One Generation Reproduction Test (MEOGRT; OECD Test Guideline 240; OECD 2015).
A variety of fish life cycle tests also include cumulative fecundity as an endpoint (OECD 2008).
References
- OECD 2008. Series on testing and assessment, Number 95. Detailed Review Paper on Fish Life-cycle Tests. OECD Publishing, Paris. ENV/JM/MONO(2008)22.
- OECD (2015), Test No. 240: Medaka Extended One Generation Reproduction Test (MEOGRT), OECD Publishing, Paris.
DOI: http://dx.doi.org/10.1787/9789264242258-en
- OECD. 2012a. Test no. 229: Fish short term reproduction assay. Paris, France:Organization for Economic Cooperation and Development.
Short Name: Increase, Plasma vitellogenin concentrations
Key Event Component
| Process |
Object |
Action |
|
vitellogenins |
increased |
AOPs Including This Key Event
Biological Context
| Level of Biological Organization |
| Organ |
Short Name: Increase, Vitellogenin synthesis in liver
Key Event Component
| Process |
Object |
Action |
| gene expression |
vitellogenins |
increased |
AOPs Including This Key Event
Biological Context
| Level of Biological Organization |
| Tissue |
Short Name: Increase, Renal pathology due to VTG deposition
Key Event Component
| Process |
Object |
Action |
| Kidney Diseases |
|
increased |
AOPs Including This Key Event
Biological Context
| Level of Biological Organization |
| Organ |
List of Adverse Outcomes in this AOP
Short Name: Decrease, Population trajectory
Key Event Component
| Process |
Object |
Action |
| population growth rate |
|
decreased |
AOPs Including This Key Event
Biological Context
| Level of Biological Organization |
| Population |
Domain of Applicability
Taxonomic Applicability
| Term |
Scientific Term |
Evidence |
Links |
| all species |
all species |
|
NCBI
|
Life Stage Applicability
| Life Stage |
Evidence |
| All life stages |
Not Specified |
Sex Applicability
| Sex |
Evidence |
| Unspecific |
Not Specified |
Consideration of population size and changes in population size over time is potentially relevant to all living organisms.
Key Event Description
Maintenance of sustainable fish and wildlife populations (i.e., adequate to ensure long-term delivery of valued ecosystem services) is an accepted regulatory goal upon which risk assessments and risk management decisions are based.
How it is Measured or Detected
Population trajectories, either hypothetical or site specific, can be estimated via population modeling based on measurements of vital rates or reasonable surrogates measured in laboratory studies. As an example, Miller and Ankley 2004 used measures of cumulative fecundity from laboratory studies with repeat spawning fish species to predict population-level consequences of continuous exposure.
Regulatory Significance of the AO
Maintenance of sustainable fish and wildlife populations (i.e., adequate to ensure long-term delivery of valued ecosystem services) is a widely accepted regulatory goal upon which risk assessments and risk management decisions are based.
References
- Miller DH, Ankley GT. 2004. Modeling impacts on populations: fathead minnow (Pimephales promelas) exposure to the endocrine disruptor 17ß-trenbolone as a case study. Ecotoxicology and Environmental Safety 59: 1-9.
Short Name: Altered, Reproductive behaviour
Key Event Component
| Process |
Object |
Action |
| reproductive behavior |
|
abnormal |
AOPs Including This Key Event
Biological Context
| Level of Biological Organization |
| Individual |
Short Name: Altered, Larval development
Key Event Component
| Process |
Object |
Action |
| larval development |
|
abnormal |
AOPs Including This Key Event
Biological Context
| Level of Biological Organization |
| Individual |
Short Name: Impaired development of, Reproductive organs
Key Event Component
| Process |
Object |
Action |
| developmental process |
reproductive organ |
abnormal |
AOPs Including This Key Event
Biological Context
| Level of Biological Organization |
| Individual |
Appendix 2
List of Key Event Relationships in the AOP
List of Adjacent Key Event Relationships
AOPs Referencing Relationship
AOPs Referencing Relationship
AOPs Referencing Relationship
Evidence Supporting Applicability of this Relationship
Taxonomic Applicability
| Term |
Scientific Term |
Evidence |
Links |
| zebrafish |
Danio rerio |
High |
NCBI
|
| fathead minnow |
Pimephales promelas |
High |
NCBI
|
Evidence Supporting this KER
Biological Plausibility
High degree of plausibility in fathead minnow, zebrafish and other cyprinid species.
Empirical Evidence
A wide range of studies using adult fish show that induction of plasma vitellogenin (VTG) occurs within 21 days in vivo aquatic exposure to estrogen receptor agonists (eg 17beta-estradiol and 4-tert pentylphenol) as shown during the successful validation of the OECD Test Guideline 229 and related protocols. A smaller number of experiment studies with fish have shown that within the OECD Test Guideline 2010, larval fish can also show induction of whole body VTG levels within 21 days aquatic exposure to estrogen receptor agonists.
Uncertainties and Inconsistencies
There are generally few inconsistencies for experimental studies using model fish species dervied from pathogen-free laboratory cultures. However, there can some uncertainties where wild fish have been used for experimental purposes.
References
Navas, J.M., Segner, H. (2006) Vitellogenin synthesis in primary cultures of fish liver cells as endpoint for in vitro screening of the (anti)estrogenic activity of chemical substances. Aquatic Toxicology 80: 1-22
Thorpe, K.L., Benstead, R., Hutchinson, T.H., Tyler, C.R. (2007). Associations between altered vitellogenin concentrations and adverse health effects in fathead minnow (Pimephales promelas). Aquatic Toxicology 85: 176-183
AOPs Referencing Relationship
Evidence Supporting Applicability of this Relationship
Publish studies specifically relate to fish, although it is plausible that the same response may occur in the aquatic life-stages of amphibians.
Evidence Supporting this KER
Biological Plausibility
High level of biological plausibility in fish.
Empirical Evidence
Laboratory in vivo aquatic exposures of fish (fathead minnow) to 17alpha-ethinylestradiol led to renal pathology within 16 weeks, concomitant with macroscopic evidence of osmoregulatory dysfunction and morbidity (Laenge et al., 2001).
Uncertainties and Inconsistencies
None that the author of this entry is aware of.
References
Herman, R.L., Kincaid, H.L. (1988) Pathological effects of orally administered 17beta-estradiol to rainbow trout. Aquaculture 72:165–172
Länge, R., Hutchinson, T.H., Croudace, C.P., Siegmund, F., Schweinfurth, H., Hampe, P., Panter, G.H., Sumpter, J.P. (2001) Effects of the synthetic estrogen 17 alpha-ethinylestradiol on the life-cycle of the fathead minnow (Pimephales promelas). Environ Toxicol Chem 20:1216-1227
AOPs Referencing Relationship
AOPs Referencing Relationship
Evidence Supporting this KER
Biological Plausibility
High level of physiological plausibility in fish.